See more : Mineral Commodities Ltd (MRC.AX) Income Statement Analysis – Financial Results
Complete financial analysis of Global Hemp Group Inc. (GBHPF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Global Hemp Group Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
You may be interested
- Sibanye Stillwater Limited (SBSW) Income Statement Analysis – Financial Results
- freenet AG (FNTN.DE) Income Statement Analysis – Financial Results
- Atlanticus Holdings Corporation 6.125% Senior Notes due 2026 (ATLCL) Income Statement Analysis – Financial Results
- 2020 Bulkers Ltd. (0FF.BE) Income Statement Analysis – Financial Results
- OKE Precision Cutting Tools Co., Ltd. (688308.SS) Income Statement Analysis – Financial Results
Global Hemp Group Inc. (GBHPF)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://globalhempgroup.com
About Global Hemp Group Inc.
Global Hemp Group Inc. engages in the production and processing of industrial hemp in the United States. It focuses on the development of sustainable and green value-added industrial hemp products utilizing the processing of the hemp plant for multi-merchantable applications. The company was formerly known as Arris Holdings Inc. and changed its name to Global Hemp Group Inc. in March 2014. Global Hemp Group Inc. was incorporated in 2009 and is headquartered in North Vancouver, Canada.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 28.88K | 2.59K | 0.00 | 0.00 | 0.00 | 11.83K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 0.00 | 0.00 | 41.27K | 7.87K | 641.00 | 4.77K | 0.00 | 0.00 | 11.47K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 0.00 | 0.00 | -41.27K | 21.01K | 1.95K | -4.77K | 0.00 | 0.00 | 367.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 72.75% | 75.23% | 0.00% | 0.00% | 0.00% | 3.10% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 17.96K | 26.18K | 29.18K | 39.07K | 4.23K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | -253.43K | 2.62M | 673.54K | 2.43M | 1.24M | 788.43K | 65.56K | 313.27K | 2.42M | 66.20K | 91.20K | 137.94K | 84.57K |
| Selling & Marketing | 0.00 | 52.35K | 207.24K | 826.00 | 60.30K | 13.19K | 4.10K | 407.00 | 1.21K | 48.51K | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 555.67K | -201.08K | 2.82M | 674.36K | 2.49M | 1.26M | 792.54K | 65.97K | 314.49K | 2.46M | 66.20K | 91.20K | 137.94K | 84.57K |
| Other Expenses | 0.00 | 1.84K | 5.28K | -31.00 | -310.88K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -262.75K | 0.00 |
| Operating Expenses | 555.67K | -184.96K | 2.90M | 725.48K | 2.54M | 1.29M | 792.54K | 65.97K | 314.49K | 2.46M | 66.20K | 91.20K | 137.94K | 84.57K |
| Cost & Expenses | 555.67K | -184.96K | 2.90M | 733.35K | 2.54M | 1.29M | 792.54K | 65.97K | 325.95K | 2.46M | 66.20K | 91.20K | 137.94K | 84.57K |
| Interest Income | 0.00 | 0.00 | 0.00 | 979.00 | 5.22K | 7.87K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 534.67K | 659.09K | 184.27K | 4.27K | 4.41K | 3.68K | 23.39K | 28.73K | 22.42K | 74.74K | 0.00 | 0.00 | 0.00 | 302.00 |
| Depreciation & Amortization | 167.90K | 228.49K | 180.93K | 21.94K | 8.66K | 4.77K | 52.52K | 22.82K | 22.42K | 0.00 | 0.00 | 25.00K | -4.50K | 302.00 |
| EBITDA | -555.67K | 184.96K | -2.73M | -1.35M | -2.48M | -1.45M | -792.54K | -65.97K | -314.12K | -2.46M | -66.20K | -66.20K | -142.44K | -84.57K |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% | -4,029.52% | -95,834.27% | 0.00% | 0.00% | 0.00% | -2,654.60% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -555.67K | 184.96K | -2.91M | -1.19M | -2.49M | -1.45M | -792.54K | -65.97K | -336.54K | -2.46M | -66.20K | -91.20K | -137.94K | -84.87K |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% | -4,105.49% | -96,168.78% | 0.00% | 0.00% | 0.00% | -2,844.10% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -2.02M | -2.35M | -5.13M | -699.21K | -383.15K | -134.78K | -20.98K | 22.00 | -190.80K | -149.19K | 0.00 | -25.00K | -258.25K | -431.74K |
| Income Before Tax | -2.58M | -2.17M | -8.04M | -1.38M | -2.92M | -1.59M | -813.52K | -65.95K | -505.29K | -2.61M | -66.20K | -116.20K | -396.19K | -516.60K |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | -4,772.88% | -112,763.25% | 0.00% | 0.00% | 0.00% | -4,270.14% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | 0.00 | 187.37K | -586.21K | -197.26K | -177.81K | 0.00 | 0.00 | -22.42K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -2.58M | -2.17M | -8.04M | -1.27M | -2.67M | -1.57M | -813.52K | -65.95K | -482.86K | -2.61M | -66.20K | -116.20K | -396.19K | -516.60K |
| Net Income Ratio | 0.00% | 0.00% | 0.00% | -4,397.25% | -103,208.81% | 0.00% | 0.00% | 0.00% | -4,080.65% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -0.17 | -0.14 | -0.60 | -0.13 | -0.29 | -0.01 | -0.01 | 0.00 | 0.00 | -0.02 | 0.00 | 0.00 | 0.00 | -0.01 |
| EPS Diluted | -0.17 | -0.14 | -0.60 | -0.13 | -0.29 | -0.01 | -0.01 | 0.00 | 0.00 | -0.02 | 0.00 | 0.00 | 0.00 | -0.01 |
| Weighted Avg Shares Out | 15.52M | 15.52M | 15.52M | 15.52M | 15.52M | 15.52M | 15.52M | 15.52M | 15.52M | 15.52M | 15.52M | 15.52M | 15.52M | 15.52M |
| Weighted Avg Shares Out (Dil) | 15.52M | 15.52M | 15.52M | 15.52M | 15.52M | 15.52M | 15.52M | 15.52M | 15.52M | 15.52M | 15.52M | 15.52M | 15.52M | 15.52M |
CSE Bulletin: Reinstatement - Global Hemp Group Inc. (GHG)
Toronto, Ontario--(Newsfile Corp. - Le 21 mai/May 2024) - Effective immediately, Global Hemp Group Inc. will be reinstated for trading. The Company has rectified the situation that gave rise to the suspension.
Invidia Capital Management Announces Healthcare Investment Firm Launch with Strategic Investment from GCM Grosvenor
Jo Natauri, Former Goldman Sachs Partner and Global Head of Private Healthcare Investing, Launches New Firm with Support of Preeminent Healthcare Executives Jo Natauri, Former Goldman Sachs Partner and Global Head of Private Healthcare Investing, Launches New Firm with Support...
OKX Partners with Hidden Road to Offer Prime Brokerage Clients Access to Deep Liquidity and Streamlined Execution of Complex Trades
SINGAPORE, May 19, 2024 /PRNewswire/ -- OKX, a leading crypto exchange and Web3 technology company, today announced a strategic partnership with Hidden Road Partners (Hidden Road), the global credit network for institutions. This partnership aims to offer a turn-key experience...
CSE Bulletin: Suspension - Global Hemp Group Inc. (GHG)
Toronto, Ontario--(Newsfile Corp. - le 16 avril/April 2024) - Effective immediately, Global Hemp Group Inc. is suspended pursuant to CSE Policy 3. The suspension is considered a Regulatory Halt as defined in National Instrument 23-101 Trading Rules.
Global Hemp Group Announces Execution of Exclusive Option Agreement to Acquire Serres Theriault (2021) Inc. ("STI"), a Multi-Facetted, Vertically Integrated Cannabis Operator in New Brunswick and Announces Private Placement
Vancouver, British Columbia--(Newsfile Corp. - January 15, 2024) - GLOBAL HEMP GROUP INC. (CSE: GHG) (OTC Pink: GBHPF) (FSE: GHG0) ("GHG" or the "Company") is pleased to announce that it has executed an Exclusive Option Agreement (the "Agreement") to acquire Serres Thériault (2021)...
CSE Bulletin: Expiry - Global Hemp Group Inc. 8SEP2023 Warrants (GHG.WT)
Toronto, Ontario--(Newsfile Corp. - Le 31 août/August 2023) - Global Hemp Group Inc. 8SEP2023 Warrants listed on September 22, 2020 will expire on September 8, 2023. Settlement Terms: All trades September 6 and 7 will settle for cash next day.
Source: https://incomestatements.info
Category: Stock Reports